Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study

The REGAIN study group

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)662-669
Number of pages8
JournalMuscle & Nerve
Volume64
Issue number6
DOIs
StatePublished - Dec 2021

ASJC Scopus Subject Areas

  • Physiology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Physiology (medical)

Keywords

  • acetylcholine receptor
  • eculizumab
  • myasthenia gravis
  • refractory
  • rituximab

Cite this